Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...

Latent Labs, the company building AI foundation models to make biology programmable, today emerged from stealth with $50M in total funding to accelerate their progress and partnerships.

The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics and machine learning company Zymergen (bought by Ginkgo Bioworks in 2022), ...

John Jumper (S.M. ’12, Ph.D. ’17) was awarded the Nobel Prize in Chemistry in 2024 for his contributions to the development of AlphaFold, an AI model that revolutionized protein structure prediction.

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer.Most Read ...

The director of the corporation’s scientific laboratory points to genomics, nuclear fusion and the development of new materials as future areas of exploration for his team ...

He and another DeepMind scientist, John Jumper, shared the 2024 Nobel Prize in Chemistry with a US professor for their breakthrough research in predicting protein structures. AI’s ability to ...

To effectively harness AI's potential, companies can adopt strategic approaches that facilitate AI adoption within their ...

AI accelerates drug development, cutting costs and boosting success rates. Discover how AI is reshaping the future of ...